Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

The Impact of Different Mobilization Strategies in the Setting of Multiple Myeloma

Francesco Mazziotta, MD, Gabriele Buda, MD PhD, Nadia Cecconi, MD, Giulia Cervetti, MD, Lorenzo Iovino, MD, Enrico Orciuolo, MD PhD, Matteo Pelosini, MD PhD, Edoardo Benedetti, MD, Francesco Caracciolo, MD, Giovanni Carulli, MD, Sara Galimberti, MD PhD, Mario Petrini, MD PhD

Blood (2019) 134 (Supplement_1): 3254.

https://doi.org/10.1182/blood-2019-126118

Published: 2019

Journal Articles

Zinc Oral Supplementation Induces a Significant Rise of TRECs and T CD4+ NaϊVe and Prevents the Increase of Ttv Viral Load after Stem Cell Transplantation: The Zenith Study

Lorenzo Iovino, MD, Enrico Orciuolo, MD PhD, Gabriele Buda, MD PhD, Giovanni Carulli, MD, Fabrizio Maggi, Dr, Daniele Focosi, MD, Riccardo Morganti, Dr, Francesca Guerrini, PhD, Sara Galimberti, MD PhD, Mario Petrini, MD PhD

Blood (2016) 128 (22): 1230.

https://doi.org/10.1182/blood.V128.22.1230.1230

Published: 2016

Journal Articles

Phase II Study of the Combination of Interleukin-2 with Zoledronic Acid As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma

Gabriele Buda, MD PhD, Rita Fazzi, Giovanni Carulli, MD, Sara Galimberti, MD PhD, Paola Sammuri, Enrico Orciuolo, MD PhD, Iacopo Petrini, Fabrizio Accardi, MD, Laura Notarfranchi, MD, Nicola Giuliani, Mario Petrini

Blood (2016) 128 (22): 5697.

https://doi.org/10.1182/blood.V128.22.5697.5697

Published: 2016

Journal Articles

Age-Dependent Influence of TNF-α Polymorphism on Progression Free Survival of ASCT In Multiple Myeloma Patients

Gabriele Buda, M.D., PhD, Alessandro Martino, PhD, Enrico Orciuolo, MD, PhD, Valentina Maggini, PhD, Francesco Lapi, Sara Galimberti, Roberto Barale, Anna Maria Rossi, Mario Petrini, MD

Blood (2010) 116 (21): 1829.

https://doi.org/10.1182/blood.V116.21.1829.1829

Published: 2010

Journal Articles

Role of Yttrium-90 Ibritumomab Tiuxetan (Zevalin®) in Inducing and Maintaining Complete Molecular Response in B Non Hodgkin’s Lymphoma Patients in Clinical Complete Remission after Chemotherapy Regimen.

Enrico Orciuolo, MD, Gabriele Buda, MD, Sara Galimberti, MD, Giuseppe Boni, MD, Nadia Cecconi, MD, Mario Petrini, MD

Blood (2007) 110 (11): 4498.

https://doi.org/10.1182/blood.V110.11.4498.4498

Published: 2007

Journal Articles

Comparison of Bone Marrow Biopsy, Flow Cytometry and PCR Assays To Detect Bone Marrow Involvement in B-Cell Non-Hodgkin Lymphomas.

Giovanni Carulli, MD, Sara Galimberti, MD, PhD, Giuseppina Bianchi, Alessandra Zucca, MD, Enrico Orciuolo, MD, Gabriele Buda, MD, Giulia Cervetti, MD, Mario Petrini, MD

Blood (2005) 106 (11): 4670.

https://doi.org/10.1182/blood.V106.11.4670.4670

Published: 2005

NARROW

The Impact of Different Mobilization Strategies in the Setting of Multiple Myeloma

Zinc Oral Supplementation Induces a Significant Rise of TRECs and T CD4+ NaϊVe and Prevents the Increase of Ttv Viral Load after Stem Cell Transplantation: The Zenith Study

Phase II Study of the Combination of Interleukin-2 with Zoledronic Acid As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma

Age-Dependent Influence of TNF-α Polymorphism on Progression Free Survival of ASCT In Multiple Myeloma Patients

Role of Yttrium-90 Ibritumomab Tiuxetan (Zevalin®) in Inducing and Maintaining Complete Molecular Response in B Non Hodgkin’s Lymphoma Patients in Clinical Complete Remission after Chemotherapy Regimen.

Comparison of Bone Marrow Biopsy, Flow Cytometry and PCR Assays To Detect Bone Marrow Involvement in B-Cell Non-Hodgkin Lymphomas.

Email alerts

ASH Publications

American Society of Hematology

The Impact of Different Mobilization Strategies in the Setting of Multiple Myeloma

Zinc Oral Supplementation Induces a Significant Rise of TRECs and T CD4+ NaϊVe and Prevents the Increase of Ttv Viral Load after Stem Cell Transplantation: The Zenith Study

Phase II Study of the Combination of Interleukin-2 with Zoledronic Acid As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma

Age-Dependent Influence of TNF-α Polymorphism on Progression Free Survival of ASCT In Multiple Myeloma Patients

Role of Yttrium-90 Ibritumomab Tiuxetan (Zevalin®) in Inducing and Maintaining Complete Molecular Response in B Non Hodgkin’s Lymphoma Patients in Clinical Complete Remission after Chemotherapy Regimen.

Comparison of Bone Marrow Biopsy, Flow Cytometry and PCR Assays To Detect Bone Marrow Involvement in B-Cell Non-Hodgkin Lymphomas.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only